Literature DB >> 21133794

Sustained reduction in the clinical incidence of methicillin-resistant Staphylococcus aureus colonization or infection associated with a multifaceted infection control intervention.

Katherine Ellingson1, Robert R Muder, Rajiv Jain, David Kleinbaum, Pei-Jean I Feng, Candace Cunningham, Cheryl Squier, Jon Lloyd, Jonathan Edwards, Val Gebski, John Jernigan.   

Abstract

OBJECTIVE: To assess the impact and sustainability of a multifaceted intervention to prevent methicillin-resistant Staphylococcus aureus (MRSA) transmission implemented in 3 chronologically overlapping phases at 1 hospital.
DESIGN: Interrupted time-series analyses.
SETTING: A Veterans Affairs hospital in the northeastern United States. PATIENTS AND PARTICIPANTS: Individuals admitted to acute care units from October 1, 1999, through September 30, 2008. To calculate the monthly clinical incidence of MRSA colonization or infection, the number of MRSA-positive cultures obtained from a clinical site more than 48 hours after admission among patients with no MRSA-positive clinical cultures during the previous year was divided by patient-days at risk. Secondary outcomes included clinical incidence of methicillin-sensitive S. aureus colonization or infection and incidence of MRSA bloodstream infections.
INTERVENTIONS: The intervention--implemented in a surgical ward beginning October 2001, in a surgical intensive care unit beginning October 2003, and in all acute care units beginning July 2005--included systems and behavior change strategies to increase adherence to infection control precautions (eg, hand hygiene and active surveillance culturing for MRSA).
RESULTS: Hospital-wide, the clinical incidence of MRSA colonization or infection decreased after initiation of the intervention in 2001, compared with the period before intervention (P = .002), and decreased by 61% (P < .001) in the 7-year postintervention period. In the postintervention period, the hospital-wide incidence of MRSA bloodstream infection decreased by 50% (P = .02), and the proportion of S. aureus isolates that were methicillin resistant decreased by 30% (P < .001).
CONCLUSIONS: Sustained decreases in hospital-wide clinical incidence of MRSA colonization or infection, incidence of MRSA bloodstream infection, and proportion of S. aureus isolates resistant to methicillin followed implementation of a multifaceted prevention program at one Veterans Affairs hospital. Findings suggest that interventions designed to prevent transmission can impact endemic antimicrobial resistance problems.

Entities:  

Mesh:

Year:  2010        PMID: 21133794     DOI: 10.1086/657665

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  22 in total

Review 1.  Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting.

Authors:  Jesús López-Alcalde; Marta Mateos-Mazón; Marcela Guevara; Lucieni O Conterno; Ivan Solà; Sheila Cabir Nunes; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2015-07-16

2.  Improving journal clubs through the use of positive deviance: A mixed-methods study.

Authors:  Alexander Anzarut; Benjamin Martens; Edward Tredget
Journal:  Can J Plast Surg       Date:  2011

3.  Cost-effectiveness of strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit.

Authors:  Courtney A Gidengil; Charlene Gay; Susan S Huang; Richard Platt; Deborah Yokoe; Grace M Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2015-01       Impact factor: 3.254

4.  Methicillin-resistant Staphylococcus aureus (MRSA) nasal real-time PCR: a predictive tool for contamination of the hospital environment.

Authors:  Daniel J Livorsi; David J Livorsi; Sana Arif; Patricia Garry; Madan G Kundu; Sarah W Satola; Thomas H Davis; Byron Batteiger; Amy B Kressel
Journal:  Infect Control Hosp Epidemiol       Date:  2015-01       Impact factor: 3.254

5.  Translating a theory-based positive deviance approach into an applied tool: Mitigating barriers among health professionals (HPs) regarding infection prevention and control (IPC) guidelines.

Authors:  Ricky Cohen; Anat Gesser-Edelsburg; Arvind Singhal; Shmuel Benenson; Allon E Moses
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

6.  Status of the implementation of the World Health Organization multimodal hand hygiene strategy in United States of America health care facilities.

Authors:  Benedetta Allegranzi; Laurie Conway; Elaine Larson; Didier Pittet
Journal:  Am J Infect Control       Date:  2014-03       Impact factor: 2.918

7.  Beyond the hospital infection control guidelines: a qualitative study using positive deviance to characterize gray areas and to achieve efficacy and clarity in the prevention of healthcare-associated infections.

Authors:  Anat Gesser-Edelsburg; Ricky Cohen; Adva Mir Halavi; Mina Zemach; Peter Vernon van Heerden; Sigal Sviri; Shmuel Benenson; Uriel Trahtemberg; Efrat Orenbuch-Harroch; Lior Lowenstein; Dan Shteinberg; Asher Salmon; Allon Moses
Journal:  Antimicrob Resist Infect Control       Date:  2018-10-24       Impact factor: 4.887

8.  Using Positive Deviance in the prevention and control of MRSA infections in a Colombian hospital: a time-series analysis.

Authors:  N M Olarte Escobar; I A Valderrama Márquez; J Avila Quiroga; T Goretty Trujillo; F González; M I Garzón Aguilar; J Escobar-Pérez
Journal:  Epidemiol Infect       Date:  2017-01-09       Impact factor: 4.434

9.  Modelling interrupted time series to evaluate prevention and control of infection in healthcare.

Authors:  V Gebski; K Ellingson; J Edwards; J Jernigan; D Kleinbaum
Journal:  Epidemiol Infect       Date:  2012-02-16       Impact factor: 4.434

Review 10.  The sustainability of new programs and innovations: a review of the empirical literature and recommendations for future research.

Authors:  Shannon Wiltsey Stirman; John Kimberly; Natasha Cook; Amber Calloway; Frank Castro; Martin Charns
Journal:  Implement Sci       Date:  2012-03-14       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.